CorMedix CRMD Deferred Tax Assets Interest Expense
Deferred Tax Assets Interest Expense at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept crmd:DeferredTaxAssetsInterestExpense.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's deferred tax assets interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's deferred tax assets interest expense?
- CorMedix (CRMD) reported deferred tax assets interest expense of $6.66M in Q4 2025.
- What does deferred tax assets interest expense mean?
- This metric captures the tax benefit arising from interest expenses that are deferred or limited under tax regulations but are expected to be deductible in future periods. It represents a future reduction in cash tax payments resulting from current or past financing costs. This is a key indicator of the company's ability to utilize interest-related tax shields.